Effect of Selexipag on Daily Life Physical Activity of Patients With Pulmonary Arterial Hypertension.
Public ClinicalTrials.gov record NCT03078907. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multi-center, Double-blind, Placebo-controlled Phase 4 Study in Patients With Pulmonary Arterial Hypertension to Assess the Effect of Selexipag on Daily Life Physical Activity and Patient's Self-reported Symptoms and Their Impacts
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary objective of this study is to evaluate the effect of selexipag on the physical activity of patients with pulmonary arterial hypertension (PAH) in their daily life, by using a wearable wrist device (actigraph). The actigraph will collect data on daily life physical activity in the patient's real environment. In addition, the PAH symptoms and their impacts will be assessed by using an electronic patient reported outcome measure in the patient's real environment. Patients will be assigned randomly to either selexipag or placebo.
Study identification
- NCT ID
- NCT03078907
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 108 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 7, 2017
- Primary completion
- Feb 9, 2020
- Completion
- Feb 9, 2020
- Last update posted
- Mar 29, 2025
2017 – 2020
United States locations
- U.S. sites
- 15
- U.S. states
- 12
- U.S. cities
- 14
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| LA Biomedical Research Institute | Torrance | California | 90502 | — |
| Northside Hospital | Atlanta | Georgia | 30342 | — |
| Kentuckiana Pulmonary Research Center | Louisville | Kentucky | 40202 | — |
| Tufts Medical Center, Pulmonary/Critical Care & Sleep | Boston | Massachusetts | 02111 | — |
| University of Nebraska Medical Center, Pulmonary, Critical Care & Sleep Medicine Division | Omaha | Nebraska | 68198 | — |
| NYU Winthrop Hospital | Mineola | New York | 11501 | — |
| UNC Pulmonary Speciality Clinic | Chapel Hill | North Carolina | 27599 | — |
| Duke University School of Medicine, Duke Pulmonary Vascular Disease center | Durham | North Carolina | 27710 | — |
| University of Cincinnati, Heart, Lung and Vascular Institute | Cincinnati | Ohio | 45267-0564 | — |
| CCF- Akron General Medical Hospital | Cleveland | Ohio | 44307 | — |
| Integris Baptist Medical Center | Oklahoma City | Oklahoma | 73112 | — |
| University of Pennsylvania, Pulmonary Vascular Disease Program | Philadelphia | Pennsylvania | 19104 | — |
| Vanderbilt University Medical Center, Care Medicine | Nashville | Tennessee | 37232-2650 | — |
| Methodist Clinical Trials | San Antonio | Texas | 78229 | — |
| University of Texas Health Science Center (San Antonio) | San Antonio | Texas | 78229 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 24 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03078907, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 29, 2025 · Synced Sep 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03078907 live on ClinicalTrials.gov.